Prof. Dr. Peter Dabrock

Chair for Systematic Theology (Ethics)

The research profile of the Chair of Systematic Theology II (Ethics) at the FAU can be characterized as foundational-theological and concrete ethics and includes in particular questions concerning bioethics and social ethics. Ethics is conceived as a discipline that detects normative questions and analyses and interprets them in regarding prerequisites and consequences, determines criteria for the assessment of conflict situations and thus also advises decision-makers at the same time, and passes on the respective knowledge and competencies to students. Peter Dabrock’s current research focuses on ethics of life sciences and biomedicine at the interface of science, technology, and society, ethics of Big Data-driven and biomarker-based medicine, ethics of AI, ethics of Pandemic response, and ethics of forms of life in the democratically framed civil society under the rule of law (social justice, demographic change, sexual ethics, public theology).

Research projects

  • VALID: Al-Driven Decision-Making in the Clinic. Ethical, Legal, and Societal Challenges
  • DigiOnko: Integrative concept for personalized precision medicine in prevention, early detection, therapy, and relapse avoidance using the example of breast cancer
  • DABIGO: data sovereignty in clinical big data regimes. Ethical, Legal, and Governance Challenges

Current projects

  • Ethische und gesellschaftliche Herausforderungen der empathokinästhetischen Sensorik

    (Third Party Funds Group – Sub project)

    Overall project: Empathokinästhetische Sensorik
    Term: 1. July 2021 - 30. June 2025
    Funding source: DFG / Sonderforschungsbereich (SFB)
    URL: https://www.empkins.de/

    In E wird ein durchlaufendes ethisches Monitoring der EmpkinS-Forschung erfolgen. Die identifizierten Fragestellungen werden mittels einer normativen Analyse theoretisch aufgegriffen und hinsichtlich ihrer Auswirkungen und Konsequenzen auf normative Vollzugsbedingungen untersucht. Durch qualitativ-empirische Untersuchungen wird eine Zuspitzung der normativen Arbeiten mit Blick auf die konkreten Herausforderungen erreicht und eine Kommunikationsplattform, zwecks einer breiten gesellschaftlichen Partizipation am SFB, aufgebaut. Ebenso werden die Grundlagen für einen multidimensionalen Perspektivansatz verantwortlicher Governance im Umgang mit EmpkinS gelegt.

  • Integratives Konzept zur personalisierten Präzisionsmedizin in Prävention, Früh-Erkennung, Therapie undRückfallvermeidung am Beispiel von Brustkrebs - DigiOnko

    (Third Party Funds Single)

    Term: 1. October 2020 - 30. September 2024
    Funding source: Bayerisches Staatsministerium für Gesundheit und Pflege, StMGP (seit 2018)
  • Integratives Konzept zur personalisierten Präzisionsmedizin in Prävention, Früh-Erkennung, Therapie und Rückfallvermeidung am Beispiel von Brustkrebs

    (Third Party Funds Single)

    Term: 1. October 2020 - 30. September 2024
    Funding source: Bayerisches Staatsministerium für Gesundheit und Pflege, StMGP (seit 2018)

    Breast cancer is one of the leading causes of death in the field of oncology in Germany. For the successful care and treatment of patients with breast cancer, a high level of information for those affected is essential in order to achieve a high level of compliance with the established structures and therapies. On the one hand, the digitalisation of medicine offers the opportunity to develop new technologies that increase the efficiency of medical care. On the other hand, it can also strengthen patient compliance by improving information and patient integration through electronic health applications. Thus, a reduction in mortality and an improvement in quality of life can be achieved. Within the framework of this project, digital health programmes are going to be created that support and complement health care. The project aims to provide better and faster access to new diagnostic and therapeutic procedures in mainstream oncology care, to implement eHealth models for more efficient and effective cancer care, and to improve capacity for patients in oncologcal therapy in times of crisis (such as the SARS-CoV-2 pandemic). The Chair of Health Management is conducting the health economic evaluation and analysing the extent to which digitalisation can contribute to a reduction in the costs of treatment and care as well as to an improvement in the quality of life of breast cancer patients.

Recent publications

2024

2023

2022

2021

2020

Related Research Fields

Contact: